MedTrace Logo

Cystoscopy and Cystodistension; Therapeutic and Aetiological Aspect in Overactive Bladder

NCT01971437 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2016-03-22

No results posted yet for this study

Summary

This is an ethically approved randomised controlled study looking at whether Cystodistension(filling the bladder with fluid under pressure) provides any benefit over cystoscopy alone (looking in the bladder) in women with refractory overactive bladder. Urine samples will also be assessed for underlying infected cause of OAB using urinalysis, microscopy and culture and cytokine assays (In collaboration with the University of Kent). We hypothesize that Cystodistension has a therapeutic benefit to women with refractory OAB and the there is an increase prevalence in chronic urinary infections with raised cytokines in women with refractory OAB.

Conditions

  • Urinary Incontinence, Urge

Interventions

PROCEDURE

Cystodistension & Cystoscopy

Women with refractory OAB receiving Cystoscopy and cystodistension

Sponsors & Collaborators

  • Medway NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Jonathan RA Duckett, FRCOG · Medway NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01971437 on ClinicalTrials.gov